Department of Occupational and Environmental Medicine, Kyung Hee University Hospital, Seoul, Korea.
Department of Preventive Medicine, School of Medicine, Kyung Hee University, Seoul, Korea.
J Gastroenterol Hepatol. 2021 Dec;36(12):3524-3531. doi: 10.1111/jgh.15568. Epub 2021 Jun 17.
Cholelithiasis is one of the most common gastrointestinal diseases worldwide. The metabolic syndrome (MetS), a combination of various metabolic abnormalities, is also common with a continually increasing prevalence. These diseases are associated with several risk factors. However, data on the association between MetS components and cholelithiasis are insufficient. This study aimed to analyze the association of MetS and its components with the incidence of cholelithiasis using national data from the Korean population.
Data were obtained from the National Health Insurance Corporation of Korea, and 207 850 individuals without cholelithiasis in 2009 were enrolled and followed up until 2013. A multivariate Cox proportional hazard model was used to calculate the adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for the incidence of cholelithiasis according to the presence of MetS and the number of MetS components. Furthermore, the risk of cholelithiasis was evaluated in individuals with a single metabolic component.
The multivariate adjusted HRs and 95% CIs for incident cholelithiasis according to 1, 2, 3, and 4-5 MetS components were 1.08 (0.93-1.24), 1.22 (1.06-1.41), 1.35 (1.17-1.57), and 1.35 (1.15-1.57), respectively (P < 0.001). This increasing trend was observed in both sexes. Compared with participants with no metabolic components, those with low high-density lipoprotein (HDL) cholesterol had a significantly increased risk for cholelithiasis (adjusted HR, 1.39 [95% CI, 1.05-1.85]).
Metabolic syndrome is a potential risk factor for cholelithiasis. Low HDL cholesterol level is the most relevant factor among MetS components for incident cholelithiasis.
胆石症是全球最常见的胃肠道疾病之一。代谢综合征(MetS)是多种代谢异常的组合,其患病率也在不断增加。这些疾病与多种危险因素有关。然而,关于 MetS 成分与胆石症之间的关联的数据还不够充分。本研究旨在利用韩国人群的国家数据,分析 MetS 及其成分与胆石症发病的相关性。
数据来自韩国国民健康保险公社,共纳入 2009 年无胆石症的 207850 名个体,并随访至 2013 年。采用多变量 Cox 比例风险模型,根据 MetS 的存在情况和 MetS 成分的数量,计算胆石症发病的调整后危险比(HR)和 95%置信区间(CI)。此外,还评估了单个代谢成分个体的胆石症发病风险。
根据存在 1、2、3 和 4-5 个 MetS 成分,发生胆石症的多变量调整 HR 和 95%CI 分别为 1.08(0.93-1.24)、1.22(1.06-1.41)、1.35(1.17-1.57)和 1.35(1.15-1.57)(P<0.001)。这种趋势在男女两性中均观察到。与没有代谢成分的参与者相比,低高密度脂蛋白(HDL)胆固醇的参与者发生胆石症的风险显著增加(调整 HR,1.39[95%CI,1.05-1.85])。
代谢综合征是胆石症的一个潜在危险因素。在 MetS 成分中,低 HDL 胆固醇水平是与胆石症发病最相关的因素。